vertigo
VERTIGO

Vertigo is having a sensation of spinning of either the surrounding or within oneself but physical movement does not exist.

It may be secondary to different causes that may be determined by numerous factors eg timing and duration, aggravating conditions or associated symptoms.
Central vertigo originates from the central nervous system (brainstem or cerebellum). It is uncommon but more serious and should be ruled out immediately.
Peripheral vertigo originates from the labyrinth or vestibular nerve.

Introduction

  • True vertigo is a type of dizziness wherein the patient experiences a false sense of spinning or rotational motion in the surroundings or within oneself even when there is no physical movement
  • May be secondary to different causes that may be determined by numerous factors eg timing and duration, aggravating conditions or associated symptoms

Timing and duration of vertigo

  • Vertigo lasting a few seconds: Acute vestibular neuronitis (late stages), Meniere’s disease (late stages)
  • Several seconds to a few minutes: Benign paroxysmal positional vertigo (BPPV), perilymphatic fistula
  • Several minutes to 1 hour: Posterior transient ischemic attack (TIA), perilymphatic fistula
  • Hours: Meniere’s disease, perilymphatic fistula from trauma or surgery, migraine, acoustic neuroma
  • Days: Early acute vestibular neuronitis, stroke, migraine, multiple sclerosis (MS)
  • Weeks: Psychogenic (vertigo lasts for weeks without improvement)

Provoking or aggravating factors

  • Changes in head position: Acute labyrinthitis, benign paroxysmal vertigo, cerebellopontine angle tumor, multiple sclerosis, perilymphatic fistula, Meniere’s disease, acute vestibular neuronitis
  • Recent upper respiratory viral infection: Acute vestibular neuronitis, acute labyrinthitis
  • Stress: Migraine, psychiatric or psychological causes
  • Immunosuppression: Herpes zoster oticus
  • Changes in ear pressure, trauma, excessive straining, loud noises: Perilymphatic fistula

Signs and Symptoms

Severity of vertigo over time

  • In acute vestibular neuronitis, initial symptoms are typically severe but lesser over the following days
  • In Meniere’s disease, vertigo attacks may occur in clusters at first, but frequency of episodes may decrease over time
  • In psychological causes, vertigo remains constant for several weeks

Associated symptoms occurring with vertigo

  • Feeling of fullness in the ear: Acoustic neuroma, Meniere’s disease
  • Ear or mastoid pain: Acoustic neuroma, acute middle ear disease, herpes zoster oticus
  • Facial weakness: Acoustic neuroma
  • Neurologic findings: Cerebellopontine angle tumor, cerebrovascular disease, multiple sclerosis
  • Headache: Acoustic neuroma, migraine
  • Hearing loss: Meniere’s disease, perilymphatic fistula, acoustic neuroma, transient ischemic attack or stroke involving anterior inferior cerebellar artery, herpes zoster oticus, cholesteatoma, otosclerosis
  • Imbalance: Acute vestibular neuronitis, cerebellopontine angle tumor, Meniere’s disease
  • Tinnitus: Acute labyrinthitis, acoustic neuroma, Meniere’s disease
  • Nausea or vomiting: Acute vestibular neuronitis, benign paroxysmal vertigo, Meniere’s disease, cerebrovascular stroke
    • If neurologic symptoms appear as well, central causes of vertigo should be considered
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 04 Apr 2019

In addition to an intensive weight loss programme, the use of continuous positive airway pressure (CPAP) could improve absolute weight loss in individuals with obesity and obstructive sleep apnoea (OSA), according to a study presented at ENDO 2019.

4 days ago
The ketogenic and Modified Atkin’s diets are effective treatments for children with refractory epilepsy of genetic aetiology, a new study suggests.
5 days ago
Extremely premature neonates who have been exposed to pre-eclampsia in utero are at high risk of developing severe respiratory distress syndrome and severe bronchopulmonary dysplasia, according to a study.
Pearl Toh, 4 days ago
A contraceptive vaginal system (Annovera) releasing a combination of segesterone acetate and ethinyl estradiol (SA/EE) effectively inhibits ovulation up to a year even at low systemic levels of SA, reports a review study presented at ENDO 2019.